MYRIAD GENETICS, INC. Operating Lease Right-of-Use Assets
MYRIAD GENETICS, INC. (MYGN) had Operating Lease Right-of-Use Assets of $50.00 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-07-31
- 2026-06-30: Operating Lease, Right-of-Use Asset $50.00M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $51.00M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $49.40M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $50.60M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $50.00M 10-Q · filed 2026-07-31 |
| 2026-03-31 | $51.00M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $49.40M 10-Q · filed 2026-07-31 |
| 2025-09-30 | $50.60M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $51.20M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $53.40M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $55.00M 10-K · filed 2026-02-24 |
| 2024-09-30 | $57.40M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $56.50M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $58.90M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $61.60M 10-K · filed 2025-02-28 |
| 2023-09-30 | $104.00M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $106.60M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $107.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $103.90M 10-K · filed 2024-02-28 |
| 2022-09-30 | $110.60M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $82.90M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $70.90M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $81.80M 10-K · filed 2023-03-01 |
| 2021-09-30 | $83.60M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $86.60M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $58.90M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $59.70M 10-K · filed 2022-02-25 |
| 2020-09-30 | $62.70M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $66.00M 10-KT · filed 2021-03-16 |
| 2020-03-31 | $64.50M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $67.30M 10-Q · filed 2020-02-07 |
| 2019-09-30 | $71.30M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $0.00 10-KT · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |